In this review, we aimed to systematically summarize what should be known by ophthalmologists about the transmission characteristics, diagnosis, and ophthalmic manifestations of the virus in order to provide reference for the prevention and control of the COVID-19 outbreak.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an ongoing global emergency public health problem.
📊
Key Findings & Data:Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an ongoing global emergency public health problem.
💡
Conclusion & Impact:In this review, we aimed to systematically summarize what should be known by ophthalmologists about the transmission characteristics, diagnosis, and ophthalmic manifestations of the virus in order to provide reference for the prevention and control of the COVID-19 outbreak.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Özet
Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an ongoing global emergency public health problem. In this review, we aimed to systematically summarize what should be known by ophthalmologists about the transmission characteristics, diagnosis, and ophthalmic manifestations of the virus in order to provide reference for the prevention and control of the COVID-19 outbreak.
🔖
Cite This Article
CERAN, B. B. (2020). Important COVID-19 Updates for Ophthalmologists. Glokom Katarakt, Cilt: 29 - Sayı: 2, 61–66. https://ajindex.com/articles/157134
References (12)
Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020İ 76:71-6 2- Sun P, Lu X, Xu C, et al. Understanding of COVID-19 based on current evidence. J Med Virol. 2020 Feb 25. 3- Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020 Feb 21. 4- Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020
Corman VM, Muth D, Niemeyer D, et al. Hosts and sources of endemic human coronaviruses. Adv Virus Res. 2018
88 6- Loon SC, Teoh SC, Oon LL, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004
Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?. Lancet Gastroenterol Hepatol. 2020
Wu F, Zhao S, Yu B. A new coronavirus associated with human respiratory disease in China. Nature. 2020
9 9- Lillie PJ, Samson A, Li A, et al. Novel coronavirus disease (Covid-19): the fi rst two patients in the UK with person to person transmission. J Infect. 2020
606 10- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. 11- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 2020
20 12- Meo SA, Alhowikan AM, Al-Khlaiwi T, et al. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERSCoV. Eur Rev Med Pharmacol Sci. 2020
Wu JT, Leung K, Bushman M, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020
10 14- Shi H, Han X, Jiang N, et al. Radiological fi ndings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020
34 15- Baud D, Qi X, Nielsen-Saines K, et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020 Mar 12. 16- Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020